Drugs / 90Y-NM600
last change Jul 2026 re-read 3 minutes ago

90Y-NM600

Developed for
metastatic malignant neoplasm
Investigated by
Archeus Technologies, Inc. · National Cancer Institute (NCI) · University of Wisconsin, Madison

Trials 1

20272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07197671 Jul 2026 → Sep 2028 expected metastatic malignant neoplasm University of Wisconsin, Madison Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 90Y-NM600 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07197671 ↗